Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
RGEN [NASD]
Repligen Corporation
Index- P/E31.68 EPS (ttm)0.50 Insider Own2.50% Shs Outstand32.04M Perf Week10.23%
Market Cap507.51M Forward P/E55.58 EPS next Y0.29 Insider Trans6.52% Shs Float30.11M Perf Month13.55%
Income16.10M PEG- EPS next Q0.09 Inst Own84.70% Short Float14.24% Perf Quarter12.10%
Sales68.20M P/S7.44 EPS this Y11.10% Inst Trans0.32% Short Ratio6.54 Perf Half Y54.54%
Book/sh3.26 P/B4.86 EPS next Y16.33% ROA14.80% Target Price16.50 Perf Year74.45%
Cash/sh1.92 P/C8.24 EPS next 5Y- ROE16.70% 52W Range7.37 - 17.26 Perf YTD16.13%
Dividend- P/FCF23.94 EPS past 5Y22.70% ROI15.40% 52W High-8.23% Beta0.97
Dividend %- Quick Ratio6.60 Sales past 5Y18.30% Gross Margin63.00% 52W Low114.93% ATR0.82
Employees116 Current Ratio7.60 Sales Q/Q-18.10% Oper. Margin33.70% RSI (14)60.50 Volatility4.53% 6.21%
OptionableYes Debt/Eq0.00 EPS Q/Q-66.70% Profit Margin23.50% Rel Volume0.69 Prev Close15.84
ShortableYes LT Debt/Eq0.00 EarningsApr 28 Payout0.00% Avg Volume655.37K Price15.84
Recom1.00 SMA2012.88% SMA507.50% SMA20028.70% Volume0 Change0.00%
07-Mar-11Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
30-Jun-09Initiated Merriman Buy
12-Jun-08Reiterated Rodman & Renshaw Mkt Outperform $11 → $9
10-Sep-07Reiterated Rodman & Renshaw Mkt Outperform $6 → $8
12-Apr-07Reiterated Rodman & Renshaw Mkt Outperform $5 → $6
19-Apr-14 12:48PM  3 Humongous Health-Care Stocks This Week at Motley Fool
15-Apr-14 05:53PM  Repligen Corporation Set to Join the S&P SmallCap 600 PR Newswire +5.12%
08-Apr-14 08:05AM  3 Stocks Spiking on Unusual Volume at TheStreet
26-Mar-14 07:30AM  Repligen Launches OPUS(R) Ready-to-Use Chromatography Columns With Largest Capacity Available on the Market GlobeNewswire
21-Mar-14 08:31AM  REPLIGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
19-Mar-14 01:04PM  REPLIGEN CORP Financials EDGAR Online Financials
14-Mar-14 11:51AM  REPLIGEN CORP Files SEC form 10-K, Annual Report EDGAR Online
06-Mar-14 01:53PM  Why Repligen Corporation Shares Were Slammed at Motley Fool -8.52%
01:53PM  Why Repligen Corporation Shares Were Slammed
10:40AM  Repligen Management Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
10:40AM  Repligen Management Discusses Q4 2013 Results - Earnings Call Transcript
09:00AM  Repligen Corporation Earnings Call scheduled for 9:00 am ET today CCBN
08:01AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:30AM  Repligen Reports Full Year and Fourth Quarter 2013 Financial Results GlobeNewswire
07:07AM  Q4 2013 Repligen Corporation Earnings Release - Before Market Open CCBN
25-Feb-14 07:30AM  Repligen to Report Fourth Quarter and Fiscal Year 2013 Financial Results GlobeNewswire
22-Jan-14 06:37PM  Lightning Round: Caterpillar, LinkedIn & More at CNBC +8.86%
04:26PM  Why Repligen Corporation Shares Jumped at Motley Fool
04:26PM  Why Repligen Corporation Shares Jumped
21-Jan-14 03:03PM  REPLIGEN CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and EDGAR Online
03:03PM  REPLIGEN CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and
11:12AM  Repligen, Continuing Overhaul, Flips Rare Disease Drugs to BioMarin at Motley Fool
11:12AM  Repligen, Continuing Overhaul, Flips Rare Disease Drugs to BioMarin
07:30AM  Repligen Announces Asset Purchase Agreement With BioMarin for HDACi Portfolio GlobeNewswire
07:30AM  Repligen Announces Asset Purchase Agreement With BioMarin for HDACi Portfolio
20-Jan-14 02:12PM  Apples To Apples: Organovo Vs. Repligen at Seeking Alpha
02:12PM  Apples To Apples: Organovo Vs. Repligen
12-Jan-14 07:08AM  How Will the Bottom Line Change for Repligen in 2014? at Motley Fool
07:08AM  How Will the Bottom Line Change for Repligen in 2014?
10-Jan-14 11:42AM  How Will the Top Line Change for Repligen in 2014? at Motley Fool
11:42AM  How Will the Top Line Change for Repligen in 2014?
01-Jan-14 12:03PM  3 Health Care Investments Immune From FDA Scrutiny at Motley Fool
12:03PM  3 Health Care Investments Immune From FDA Scrutiny
13-Dec-13 10:08AM  What Should Investors Expect From Repligen in 2014? at Motley Fool
10:08AM  What Should Investors Expect From Repligen in 2014?
05-Dec-13 10:04PM  Fundamentally Attractive Biotechnology "Pick & Shovel" Companies at Seeking Alpha
10:04PM  Fundamentally Attractive Biotechnology "Pick & Shovel" Companies
26-Nov-13 07:30AM  Repligen to Present at the 25th Annual Piper Jaffray Healthcare Conference GlobeNewswire
07:30AM  Repligen to Present at the 25th Annual Piper Jaffray Healthcare Conference
24-Nov-13 01:55PM  Repligen-My Projections For The Income Statement: 2013 -2019 at Seeking Alpha
01:55PM  Repligen - My Projections For The Income Statement: 2013-2019 at Seeking Alpha
01:55PM  Repligen - My Projections For The Income Statement: 2013-2019
22-Nov-13 02:01PM  5 Biotech Trends Powering Repligen's Growth at Motley Fool
02:01PM  5 Biotech Trends Powering Repligen's Growth
19-Nov-13 04:48PM  The Simplest Biotech Growth Portfolio Ever at Motley Fool
04:48PM  The Simplest Biotech Growth Portfolio Ever
04:12PM  REPLIGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
04:12PM  REPLIGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
02:58PM  Repligen names Biogen executive to its board AP
02:58PM  Repligen names Biogen executive to its board
02:00PM  Repligen Appoints Biogen Idec Executive John G. Cox to Board of Directors GlobeNewswire
17-Nov-13 08:46PM  Repligen's 3 Most Important Customers at Motley Fool
15-Nov-13 11:04AM  What the End of Bristol-Myers Squibb Royalties Means for Repligen at Motley Fool
14-Nov-13 01:04PM  REPLIGEN CORP Financials EDGAR Online Financials
08-Nov-13 02:23PM  REPLIGEN CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
12:28AM  Repligen Triples Earnings, but Bad News Awaits in 2014 at Motley Fool
07-Nov-13 03:40PM  Repligen Management Discusses Q3 2013 Results - Earnings Call Transcript at Seeking Alpha
09:00AM  Repligen Corporation Earnings Call scheduled for 9:00 am ET today CCBN
08:55AM  Repligen Corporation Discusses Q3 2013 Results (Webcast) at Seeking Alpha
08:38AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:36AM  Repligen Corporation Earnings Call scheduled for 9:00 am ET today CCBN
07:30AM  Repligen Reports Third Quarter 2013 Financial Results GlobeNewswire
07:07AM  Q3 2013 Repligen Corporation Earnings Release - Before Market Open CCBN
06-Nov-13 07:30AM  Repligen to Present at the 2013 Stephens Fall Investment Conference GlobeNewswire
04-Nov-13 04:38PM  Meet the Tiny Biotech Challenging Amgen and General Electric at Motley Fool
01-Nov-13 07:30AM  Repligen Completes Expansion of U.S. Manufacturing Facility GlobeNewswire
01:06AM  5 Biotechnology Bargains With Attractive Fundamentals at Seeking Alpha
24-Oct-13 06:49PM  1 Hidden Gem Powering the Biotech Industry at Motley Fool
07:30AM  Repligen to Report Third Quarter 2013 Financial Results GlobeNewswire
13-Sep-13 04:31PM  REPLIGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
04-Sep-13 08:00AM  Repligen to Present at the Stifel Healthcare Conference 2013 GlobeNewswire
07:10AM  Repligen receives first milestone payment from Pfizer for SMA program theflyonthewall.com
07:03AM  InPlay: Repligen receives first milestone payment from Pfizer (PFE) under licensing agreement for spinal muscular atrophy program Briefing.com
07:00AM  Repligen Receives First Milestone Payment From Pfizer Under Licensing Agreement for Spinal Muscular Atrophy Program GlobeNewswire
28-Aug-13 05:07PM  REPLIGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
19-Aug-13 01:17PM  Repligen: A Buy And Hold Stock, OPUS Could Be A Dynamic New Product at Seeking Alpha
15-Aug-13 01:04PM  REPLIGEN CORP Financials EDGAR Online Financials
07-Aug-13 10:11AM  REPLIGEN CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
04-Aug-13 09:31AM  5 Stocks Energizing Investors After Earnings at Wall St. Cheat Sheet
01-Aug-13 01:52PM  Repligen Earnings: Heres Why the Stock is Up Now at Wall St. Cheat Sheet
09:00AM  Repligen Corporation Earnings Call scheduled for 9:00 am ET today CCBN
07:30AM  Repligen Reports Second Quarter 2013 Financial Results GlobeNewswire
07:07AM  Q2 2013 Repligen Corporation Earnings Release - Before Market Open CCBN
12:44AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
18-Jul-13 07:30AM  Repligen to Report Second Quarter 2013 Financial Results GlobeNewswire
24-Jun-13 10:40AM  MELA Sciences Director Buys 3K Shares and 4 Insider Buys to Note at Wall St. Cheat Sheet
18-Jun-13 09:50AM  Why Repligen Is Ready to Rebound at Motley Fool
23-May-13 01:39PM  Repligen CEO to Present at Jefferies 2013 Global Healthcare Conference GlobeNewswire
14-May-13 01:04PM  REPLIGEN CORP Financials EDGAR Online Financials
10-May-13 03:34PM  Repligen Stock Sees Short Interest Move 24.7% Higher at Forbes
09:32AM  REPLIGEN CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
07-May-13 06:56AM  REPLIGEN CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
03-May-13 11:55PM  Repligen's CEO Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha
02-May-13 09:00AM  Repligen Corporation Earnings Call scheduled for 9:00 am ET today CCBN
07:36AM  InPlay: Repligen reports Q1 results, revs rose 28% YoY to $16.5 mln, provides guidance for 2013 Briefing.com
07:30AM  Repligen Reports First Quarter 2013 Financial Results GlobeNewswire
07:07AM  Q1 2013 Repligen Corporation Earnings Release - Before Market Open CCBN
01:48AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
01-May-13 11:32AM  Incremental Changes in Regulatory Environment Beneficial to Development-Stage Biotech Companies Due to Emphasis on Closer Working Relationships with the FDA and Drug Sponsors Wall Street Transcript
24-Apr-13 04:40PM  Isis Pharma's ISIS-SMNRx Progresses Zacks
Repligen Corporation, a life sciences company, develops, manufactures, and markets consumable bioprocessing products for use in the production of monoclonal antibodies and other biologic drugs. The company manufactures various forms of Protein A, a critical reagent used in biomanufacturing to separate and purify monoclonal antibodies. It also supplies various growth factor products, which are used to increase cell growth and productivity during upstream fermentation. In addition, the company manufactures and sells chromatography products, including OPUS pre-packed columns for biologics purification, as well as proprietary Protein A media and quality test kits. Further, it has a portfolio of therapeutic product candidates, which include RG3039, a small molecule drug candidate in clinical development for spinal muscular atrophy; histone deacetylase inhibitor for the treatment of Friedreich's ataxia disease; and RG1068, a synthetic human hormone developed as a novel imaging agent for the detection of pancreatic duct abnormalities in combination with magnetic resonance imaging in patients with pancreatitis and other related diseases. The company sells its bioprocessing products are to various life sciences companies, biopharmaceutical manufacturing companies, and contract manufacturing organizations worldwide. Repligen Corporation was founded in 1981 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RUSCHE JAMES RSenior Vice PresidentApr 15Buy3.0525,00076,250151,270Apr 15 04:53 PM
WITT DANIEL PSenior Vice PresidentApr 15Buy3.0510,00030,50057,709Apr 15 04:51 PM
RUSCHE JAMES RSenior Vice PresidentAug 08Sale10.0130,000300,354137,270Aug 09 11:39 AM
RUSCHE JAMES RSenior Vice PresidentAug 07Option Exercise5.8750,000293,500197,128Aug 09 11:39 AM
DAWES KAREN ADirectorJun 21Buy7.701,0007,70033,880Jun 21 02:16 PM
RYAN THOMAS F JRDirectorMay 17Sale9.007,00063,0300May 20 12:04 PM
RYAN THOMAS F JRDirectorMay 17Sale8.9510,00089,52448,380May 20 12:04 PM
RYAN THOMAS F JRDirectorMay 16Sale8.954,00035,80158,380May 20 12:04 PM
RYAN THOMAS F JRDirectorMay 15Option Exercise3.1014,88446,14073,883May 15 03:21 PM
RYAN THOMAS F JRDirectorMay 15Sale8.9614,884133,42358,999May 15 03:21 PM
RYAN THOMAS F JRDirectorMay 15Sale9.001,96117,64362,380May 16 02:16 PM
HERLIHY WALTER CPRESIDENT, CEOMay 15Sale8.851,51413,399537,793May 16 08:28 AM
RYAN THOMAS F JRDirectorMay 14Option Exercise3.3815,11651,06076,038May 15 03:21 PM
HERLIHY WALTER CPRESIDENT, CEOMay 14Sale8.9838,486345,450549,307May 16 08:28 AM
RYAN THOMAS F JRDirectorMay 14Sale8.9517,155153,49058,999May 15 03:21 PM
RYAN THOMAS F JRDirectorMay 13Option Exercise5.9954,000323,490100,038May 15 03:21 PM
RYAN THOMAS F JRDirectorMay 13Sale9.0454,000488,26361,038May 15 03:21 PM
Kelly William JChief Accounting OfficerMay 07Option Exercise4.8220,00096,40020,000May 08 02:46 PM
Kelly William JChief Accounting OfficerMay 07Sale9.1420,000182,7340May 08 02:46 PM
Benjamin HowardVP Business DevelopmentMay 06Option Exercise3.8522,96488,39726,731May 07 01:42 PM
HERLIHY WALTER CPRESIDENT, CEOMay 03Option Exercise4.59150,000688,700627,838May 06 03:33 PM